Nevertheless, in tumor cells, Keap1 inactivation leads to an increase in the stability and activity of NRF2, subsequently activating numerous target genes involved in GPX4–GSH-mediated ferroptosis defense, including SLC7A11, thereby facilitating the protection of cancer cells from ferroptosis [46]. The gene discussed is KEAP1; the disease is cancer.